全部文献期刊学位论文会议报纸专利标准年鉴图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Tsu-Yi Chao , Der-Ming Chu ...
来源:[J].BMC Pediatrics(IF 1.982), 2016, Vol.16 (1)Springer
摘要:Abstract(#br) Background(#br)Children with longstanding use of antiepileptic drugs (AEDs) are susceptible to developing low bone mineral density and an increased fracture risk. However, the literature regarding the effects of AEDs on growth in epileptic children is limited. ...
作者:... Michael Hsiao , Chi-Tai Yeh , Tsu-Yi Chao
来源:[J].BMC Cancer(IF 3.333), 2016, Vol.16 (1)Springer
摘要:Abstract(#br) Background(#br)Triple negative breast cancers (TNBC) possess cell dedifferentiation characteristics, carry out activities connate to those of cancer stem cells (CSCs) and are associated with increased metastasis, as well as, poor clinical prognosis. The regulatory m...
作者:Tsu-Yi Chao , Ruey-Kuen Hsieh ...
来源:[J].BMC Cancer(IF 3.333), 2016, Vol.16 (1)Springer
摘要:Abstract(#br) Background(#br)PEP02 (also known as MM-398, nal-IRI) is a novel nanoparticle formulation of irinotecan encapsulated in liposomes. The aims of this study were to investigate the dose-limiting toxicity (DLT), maximum tolerated dose (MTD) and pharmacokinetics (PK) of P...
作者:... Jen-Shen Huang , Tzu-Chuan Huang , Tsu-Yi Chao
来源:[J].Journal of Cancer Research and Therapeutics(IF 0.761), 2013, Vol.9 (4), pp.653-659DOAJ
摘要:Aim of study: To investigate the features, adverse effects, bone marker changes in patients with breast cancer, prostate cancer, and multiple myeloma with bone metastases under Zometa® therapy.Materials and Methods: This post-marketing study included 414 Taiwanese patients w...
作者:Tsu-Yi Chao , Ching-Liang Ho ...
来源:[J].Journal of Biomedical Science(IF 2.458), 2004, Vol.11 (4), pp.511-516Springer
摘要:Abstract(#br)Diagnosis and follow-up of bone metastases in breast cancer patients usually rely on symptoms and imaging studies. Tartrate-resistant acid phosphatase 5b (TRACP 5b) is a specific marker of osteoclasts and is herein proposed as a marker of bone metastasis in brea...
作者:Tsu-Yi Chao , Dar-Ren Chen ...
来源:[J].Breast Cancer Research and Treatment(IF 4.469), 2018, Vol.170 (3), pp.583-591Springer
摘要:Abstract(#br) Purpose(#br)The aim of this study was to confirm the therapeutic role of eribulin on Taiwanese women with metastatic breast cancer.(#br) Methods(#br)This retrospective study examined 449 females who received eribulin between March 2014 and June 2017 at 14 hospi...
作者:... Hung Chang , Harn-Jing Terng , Tsu-Yi Chao
来源:[J].Journal of the Formosan Medical Association(IF 1), 2016Elsevier
摘要:Background/Purpose(#br)Lung cancer is a heterogeneous disease with varied outcomes. Molecular markers are eagerly investigated to predict a patient's treatment response or outcome. Previous studies used frozen biopsy tissues to identify crucial genes as prognostic markers. We exp...
作者:... Wei-You Kao , Yeu-Chin Chen , Tsu-Yi Chao
来源:[J].Journal of the Formosan Medical Association(IF 1), 2012, Vol.111 (1), pp.34-40Elsevier
摘要:Background/Purpose(#br)The activating JAK2 mutation with a G-C to T-A transversion at codon 617 ( JAK2 V617F ) is associated with myeloproliferative neoplasms (MPNs), including polycythemia vera (PV), essential thrombocythemia (ET), and myelofibrosis. Here, we report a technical ...
作者:... Jen-Shen Huang , Tzu-Chuan Huang , Tsu-Yi Chao
来源:[J].Journal of Cancer Research and Therapeutics(IF 0.761), 2013, Vol.9 (4), pp.653-659Wolters Kluwer
摘要:Aim of study: To investigate the features, adverse effects, bone marker changes in patients with breast cancer, prostate cancer, and multiple myeloma with bone metastases under Zometa® therapy. Materials and Methods: This post-marketing study included 414 Taiwanese patients ...
作者:Tsu-Yi Chao , Yuh-Feng Lin ...
来源:[J].American Journal of Kidney Diseases(IF 5.294), 2003, Vol.41 (5), pp.1052-1059Elsevier
摘要:Abstract(#br)Background:(#br)Serum tartrate-resistant acid phosphatase 5b (TRACP) is a new marker of potential clinical use to monitor osteoclastic activity and bone resorption rate. The relationship between histomorphometric parameters of bone resorption and serum TRACP was...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×